- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SOPH
Recent news which mentions SOPH
Earnings Scheduled For August 9, 2022
August 09, 2022
From Benzinga
From Benzinga
63 Biggest Movers From Yesterday
June 17, 2022
From Benzinga
37 Stocks Moving In Thursday's Mid-Day Session
June 16, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
June 06, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
From Benzinga
Tickers
SOPH
From Motley Fool
Earnings Scheduled For May 10, 2022
May 10, 2022
From Benzinga
27 Recession-Resistant Stocks To Look At Now
May 09, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
April 08, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
March 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
March 25, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 24, 2022
From Benzinga
Sophia Genetics SA (SOPH) Q4 2021 Earnings Call Transcript
March 15, 2022
Tickers
SOPH
From Motley Fool
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
From Benzinga
Earnings Scheduled For March 15, 2022
March 15, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 19, 2022
From Benzinga
65 Biggest Movers From Yesterday
January 19, 2022
From Benzinga
52 Biggest Movers From Friday
January 18, 2022
From Benzinga
30 Stocks Moving In Friday's Mid-Day Session
January 14, 2022
From Benzinga
Sophia Genetics SA (SOPH) Q3 2021 Earnings Call Transcript
November 11, 2021
Tickers
SOPH
From Motley Fool
Earnings Scheduled For September 9, 2021
September 09, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2021
August 17, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
From Benzinga
The IPO Recap – Party Is Everything But Over
July 28, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.